Showing 38,381 - 38,400 results of 125,680 for search '(( a n decrease ) OR ( 5 ((step decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 1.91s Refine Results
  1. 38381

    Image_2_Anaplasma phagocytophilum Ankyrin A Protein (AnkA) Enters the Nucleus Using an Importin-β-, RanGTP-Dependent Mechanism.jpeg by Yuri Kim (214452)

    Published 2022
    “…Truncation of the first four AnkA N-terminal ARs (AR1-4), but not other regions, prevents AnkA nuclear accumulation. …”
  2. 38382

    Table_2_Anaplasma phagocytophilum Ankyrin A Protein (AnkA) Enters the Nucleus Using an Importin-β-, RanGTP-Dependent Mechanism.xlsx by Yuri Kim (214452)

    Published 2022
    “…Truncation of the first four AnkA N-terminal ARs (AR1-4), but not other regions, prevents AnkA nuclear accumulation. …”
  3. 38383

    Image_1_Anaplasma phagocytophilum Ankyrin A Protein (AnkA) Enters the Nucleus Using an Importin-β-, RanGTP-Dependent Mechanism.jpeg by Yuri Kim (214452)

    Published 2022
    “…Truncation of the first four AnkA N-terminal ARs (AR1-4), but not other regions, prevents AnkA nuclear accumulation. …”
  4. 38384

    Image_3_Anaplasma phagocytophilum Ankyrin A Protein (AnkA) Enters the Nucleus Using an Importin-β-, RanGTP-Dependent Mechanism.jpeg by Yuri Kim (214452)

    Published 2022
    “…Truncation of the first four AnkA N-terminal ARs (AR1-4), but not other regions, prevents AnkA nuclear accumulation. …”
  5. 38385

    Image_4_Anaplasma phagocytophilum Ankyrin A Protein (AnkA) Enters the Nucleus Using an Importin-β-, RanGTP-Dependent Mechanism.pdf by Yuri Kim (214452)

    Published 2022
    “…Truncation of the first four AnkA N-terminal ARs (AR1-4), but not other regions, prevents AnkA nuclear accumulation. …”
  6. 38386

    Table_1_Anaplasma phagocytophilum Ankyrin A Protein (AnkA) Enters the Nucleus Using an Importin-β-, RanGTP-Dependent Mechanism.pdf by Yuri Kim (214452)

    Published 2022
    “…Truncation of the first four AnkA N-terminal ARs (AR1-4), but not other regions, prevents AnkA nuclear accumulation. …”
  7. 38387

    Online search strategies utilized in feigning attention deficit/hyperactivity disorder (ADHD) while performing a continuous performance test (CPT) by Daniella Winter (13143553)

    Published 2022
    “…</p> <p>Simulators (<i>n</i> = 39) searched for information before undergoing an evaluation which included performing a continuous performance test (CPT). …”
  8. 38388

    Data Sheet 1_Yerba Maté and its impact on glycemic control and metabolic health: a systematic review and meta-analysis.docx by Daiping Li (5007932)

    Published 2025
    “…The results with pre-diabetes patients suggest significant decreases in postprandial glucose (MD -12.76, 95% CI -16.78, -8.74; N = 2), HbA1c (MD -0.37, 95% CI -0.56, -0.18; N = 2), and the homeostatic model assessment index (HOMA index) (MD -0.24, 95% CI -0.37, -0.11; N = 2), though further research is needed to confirm these findings. …”
  9. 38389

    Data Sheet 3_Yerba Maté and its impact on glycemic control and metabolic health: a systematic review and meta-analysis.doc by Daiping Li (5007932)

    Published 2025
    “…The results with pre-diabetes patients suggest significant decreases in postprandial glucose (MD -12.76, 95% CI -16.78, -8.74; N = 2), HbA1c (MD -0.37, 95% CI -0.56, -0.18; N = 2), and the homeostatic model assessment index (HOMA index) (MD -0.24, 95% CI -0.37, -0.11; N = 2), though further research is needed to confirm these findings. …”
  10. 38390

    Data Sheet 2_Yerba Maté and its impact on glycemic control and metabolic health: a systematic review and meta-analysis.docx by Daiping Li (5007932)

    Published 2025
    “…The results with pre-diabetes patients suggest significant decreases in postprandial glucose (MD -12.76, 95% CI -16.78, -8.74; N = 2), HbA1c (MD -0.37, 95% CI -0.56, -0.18; N = 2), and the homeostatic model assessment index (HOMA index) (MD -0.24, 95% CI -0.37, -0.11; N = 2), though further research is needed to confirm these findings. …”
  11. 38391
  12. 38392

    Table_1_Differences in SARS-CoV-2-Specific Antibody Responses After the First, Second, and Third Doses of BNT162b2 in Naïve and Previously Infected Individuals: A 1-Year Observatio... by Manca Ogrič (12696659)

    Published 2022
    “…Background<p>Safe and effective vaccines against COVID-19 are critical for preventing the spread of SARS-CoV-2, but little is known about the humoral immune response more than 9 months after vaccination. …”
  13. 38393

    Table_2_Slow-Breathing Curriculum for Stress Reduction in High School Students: Lessons Learned From a Feasibility Pilot.docx by Tanya G. K. Bentley (4099675)

    Published 2022
    “…Breath practice compliance ranged from 29 to 83% across classes and weeks, and decreased on average over the 5 weeks. Compliance with the breath science videos ranged from 43 to 86%, and that with the weekly STAI-State and CO<sub>2</sub>TT measures varied from 36 to 86%. …”
  14. 38394

    Table_3_Slow-Breathing Curriculum for Stress Reduction in High School Students: Lessons Learned From a Feasibility Pilot.docx by Tanya G. K. Bentley (4099675)

    Published 2022
    “…Breath practice compliance ranged from 29 to 83% across classes and weeks, and decreased on average over the 5 weeks. Compliance with the breath science videos ranged from 43 to 86%, and that with the weekly STAI-State and CO<sub>2</sub>TT measures varied from 36 to 86%. …”
  15. 38395

    Table_7_Slow-Breathing Curriculum for Stress Reduction in High School Students: Lessons Learned From a Feasibility Pilot.docx by Tanya G. K. Bentley (4099675)

    Published 2022
    “…Breath practice compliance ranged from 29 to 83% across classes and weeks, and decreased on average over the 5 weeks. Compliance with the breath science videos ranged from 43 to 86%, and that with the weekly STAI-State and CO<sub>2</sub>TT measures varied from 36 to 86%. …”
  16. 38396

    Table_8_Slow-Breathing Curriculum for Stress Reduction in High School Students: Lessons Learned From a Feasibility Pilot.docx by Tanya G. K. Bentley (4099675)

    Published 2022
    “…Breath practice compliance ranged from 29 to 83% across classes and weeks, and decreased on average over the 5 weeks. Compliance with the breath science videos ranged from 43 to 86%, and that with the weekly STAI-State and CO<sub>2</sub>TT measures varied from 36 to 86%. …”
  17. 38397

    Table_6_Slow-Breathing Curriculum for Stress Reduction in High School Students: Lessons Learned From a Feasibility Pilot.docx by Tanya G. K. Bentley (4099675)

    Published 2022
    “…Breath practice compliance ranged from 29 to 83% across classes and weeks, and decreased on average over the 5 weeks. Compliance with the breath science videos ranged from 43 to 86%, and that with the weekly STAI-State and CO<sub>2</sub>TT measures varied from 36 to 86%. …”
  18. 38398

    Table_4_Slow-Breathing Curriculum for Stress Reduction in High School Students: Lessons Learned From a Feasibility Pilot.docx by Tanya G. K. Bentley (4099675)

    Published 2022
    “…Breath practice compliance ranged from 29 to 83% across classes and weeks, and decreased on average over the 5 weeks. Compliance with the breath science videos ranged from 43 to 86%, and that with the weekly STAI-State and CO<sub>2</sub>TT measures varied from 36 to 86%. …”
  19. 38399

    Table_1_Slow-Breathing Curriculum for Stress Reduction in High School Students: Lessons Learned From a Feasibility Pilot.docx by Tanya G. K. Bentley (4099675)

    Published 2022
    “…Breath practice compliance ranged from 29 to 83% across classes and weeks, and decreased on average over the 5 weeks. Compliance with the breath science videos ranged from 43 to 86%, and that with the weekly STAI-State and CO<sub>2</sub>TT measures varied from 36 to 86%. …”
  20. 38400

    Characterization of a Novel Small Molecule Subtype Specific Estrogen-Related Receptor α Antagonist in MCF-7 Breast Cancer Cells by Michael J. Chisamore (263944)

    Published 2009
    “…Research suggests that ERRα may be a novel drug target to treat breast cancer and/or metabolic disorders and this has led to an effort to characterize the mechanisms of action of N-[(2Z)-3-(4,5-dihydro-1,3-thiazol-2-yl)-1,3-thiazolidin-2-yl idene]-5H dibenzo[a,d]<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0005624#pone.0005624-Vanacker1">[7]</a>annulen-5-amine, a novel ERRα specific antagonist.…”